Hoppe, Antje <br/><br/>
Serum cystatin C is a better marker of topotecan clearance than serum creatinine.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Apr 2005 
 - 3038-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-04-2086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Biomarkers--blood<br/>Creatine--blood<br/>Cystatin C<br/>Cystatins--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Models, Biological<br/>Prospective Studies<br/>Topotecan--administration & dosage